tradingkey.logo

Zynex Inc

ZYXI

1.550USD

0.000
Cierre 09/19, 16:00ETCotizaciones retrasadas 15 min
47.55MCap. mercado
25.22P/E TTM
Más Datos de Zynex Inc Compañía
Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.
Información de la empresa
Símbolo de cotizaciónZYXI
Nombre de la empresaZynex Inc
Fecha de salida a bolsaNov 27, 2002
Director ejecutivoMr. Steven Lewis Dyson
Número de empleados1000
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 27
Dirección9655 Maroon Circle
CiudadENGLEWOOD
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal80112
Teléfono18004956670
Sitio Webhttps://www.zynex.com/
Símbolo de cotizaciónZYXI
Fecha de salida a bolsaNov 27, 2002
Director ejecutivoMr. Steven Lewis Dyson
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thomas Sandgaard
Mr. Thomas Sandgaard
Chairman of the Board
Chairman of the Board
14.31M
-10.72%
Mr. Barry D. Michaels
Mr. Barry D. Michaels
Independent Director
Independent Director
83.33K
+13.64%
Mr. Michael D. Cress
Mr. Michael D. Cress
Independent Director
Independent Director
83.33K
+13.64%
Ms. Anna Lucsok
Ms. Anna Lucsok
Chief Operating Officer
Chief Operating Officer
50.27K
+7.96%
Mr. Quinn Callanan
Mr. Quinn Callanan
IR Contact Officer
IR Contact Officer
--
--
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Independent Director
Independent Director
--
--
Mr. Vikram Singh Bajaj
Mr. Vikram Singh Bajaj
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. John T. Bibb
Mr. John T. Bibb
Chief Legal Officer, Company Secretary
Chief Legal Officer, Company Secretary
--
--
Mr. Steven Lewis Dyson
Mr. Steven Lewis Dyson
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thomas Sandgaard
Mr. Thomas Sandgaard
Chairman of the Board
Chairman of the Board
14.31M
-10.72%
Mr. Barry D. Michaels
Mr. Barry D. Michaels
Independent Director
Independent Director
83.33K
+13.64%
Mr. Michael D. Cress
Mr. Michael D. Cress
Independent Director
Independent Director
83.33K
+13.64%
Ms. Anna Lucsok
Ms. Anna Lucsok
Chief Operating Officer
Chief Operating Officer
50.27K
+7.96%
Mr. Quinn Callanan
Mr. Quinn Callanan
IR Contact Officer
IR Contact Officer
--
--
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Independent Director
Independent Director
--
--
Desglose de ingresos
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2023
FY2022
FY2021
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
26.58M
0.00%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mar., 19 de ago
Actualizado: mar., 19 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Sandgaard (Thomas)
47.24%
The Vanguard Group, Inc.
3.13%
Two Sigma Investments, LP
1.71%
BlackRock Institutional Trust Company, N.A.
1.67%
Janney Montgomery Scott LLC
1.45%
Otro
44.80%
Accionistas
Accionistas
Proporción
Sandgaard (Thomas)
47.24%
The Vanguard Group, Inc.
3.13%
Two Sigma Investments, LP
1.71%
BlackRock Institutional Trust Company, N.A.
1.67%
Janney Montgomery Scott LLC
1.45%
Otro
44.80%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
48.31%
Investment Advisor
7.08%
Hedge Fund
5.13%
Investment Advisor/Hedge Fund
3.57%
Research Firm
2.49%
Venture Capital
0.06%
Otro
33.36%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
311
21.33M
70.41%
-5.95M
2025Q1
324
21.34M
70.57%
-6.08M
2024Q4
334
24.74M
77.69%
-3.41M
2024Q3
331
25.30M
79.66%
-3.32M
2024Q2
334
26.14M
82.22%
-2.87M
2024Q1
344
26.41M
82.67%
-3.54M
2023Q4
343
26.23M
77.32%
-4.18M
2023Q3
329
26.70M
74.31%
-5.97M
2023Q2
335
29.53M
80.56%
-2.04M
2023Q1
333
27.95M
76.25%
-3.19M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Sandgaard (Thomas)
14.31M
47.33%
-1.72M
-10.72%
Mar 18, 2025
The Vanguard Group, Inc.
1.05M
3.47%
-11.28K
-1.06%
Mar 31, 2025
Two Sigma Investments, LP
272.03K
0.9%
+68.89K
+33.91%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.09M
3.6%
-9.59K
-0.87%
Mar 31, 2025
Janney Montgomery Scott LLC
149.04K
0.49%
-10.22K
-6.41%
Mar 31, 2025
Arrowstreet Capital, Limited Partnership
258.19K
0.85%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
387.00K
1.28%
-56.02K
-12.65%
Mar 31, 2025
Renaissance Technologies LLC
150.26K
0.5%
+12.90K
+9.39%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI